Newswise: COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds

Newswise: COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds. ” A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group. The results add to a body of evidence indicating that SSRIs may have beneficial effects against the worst symptoms of COVID-19, although large randomized clinical trials are needed to prove this.”

Leave a Reply

%d bloggers like this: